D
CRISPR Therapeutics AG CRSP
$41.86 $3.298.53% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -86.13% -89.95% 19.31% 18.89% 171.01%
Total Other Revenue -- -- -- -- --
Total Revenue -86.13% -89.95% 19.31% 18.89% 171.01%
Cost of Revenue -12.20% -16.75% -9.54% -12.54% -11.77%
Gross Profit -76.34% -168.89% 23.85% 26.45% 51.19%
SG&A Expenses 3.57% -4.18% -11.77% -19.38% -25.88%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -10.22% -15.14% -9.84% -13.49% -13.84%
Operating Income -58.86% -109.66% 21.54% 25.12% 46.83%
Income Before Tax -77.66% -140.62% 34.38% 37.90% 59.20%
Income Tax Expenses 73.30% 24.20% 145.74% 134.02% 187.72%
Earnings from Continuing Operations -77.61% -138.43% 32.23% 36.09% 58.56%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -77.61% -138.43% 32.23% 36.09% 58.56%
EBIT -58.86% -109.66% 21.54% 25.12% 46.83%
EBITDA -63.16% -120.67% 22.29% 25.97% 48.19%
EPS Basic -67.30% -123.71% 37.49% 39.60% 59.84%
Normalized Basic EPS -67.36% -125.77% 39.50% 41.31% 60.46%
EPS Diluted -65.52% -121.12% 36.73% 39.02% 59.41%
Normalized Diluted EPS -65.95% -123.12% 39.00% 40.89% 60.12%
Average Basic Shares Outstanding 6.74% 6.48% 5.11% 3.72% 2.38%
Average Diluted Shares Outstanding 6.20% 5.94% 5.63% 4.24% 2.90%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --